{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T18:47:05Z","timestamp":1747162025092,"version":"3.40.5"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"French Clinical Research Program","award":["PHRC 2004\/37"],"award-info":[{"award-number":["PHRC 2004\/37"]}]}],"content-domain":{"domain":["clinicalkey.jp","ijaaonline.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.ijantimicag.2017.03.027","type":"journal-article","created":{"date-parts":[[2017,7,8]],"date-time":"2017-07-08T03:46:24Z","timestamp":1499485584000},"page":"359-364","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effectiveness of and obstacles to antibiotic streamlining to amoxicillin monotherapy in bacteremic pneumococcal pneumonia"],"prefix":"10.1016","volume":"50","author":[{"given":"Mathieu","family":"Blot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8225-9248","authenticated-orcid":false,"given":"Diane","family":"Pivot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abderrahmane","family":"Bourredjem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnaud","family":"Salmon-Rousseau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"de Curraize","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delphine","family":"Croisier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Chavanet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Binquet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lionel","family":"Piroth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"author":"European Centre for Disease Prevention and Control","key":"10.1016\/j.ijantimicag.2017.03.027_bib0010"},{"key":"10.1016\/j.ijantimicag.2017.03.027_bib0015","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1086\/648678","article-title":"Etiology of community-acquired pneumonia: increased microbiological yield with new diagnostic methods","volume":"50","author":"Johansson","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.03.027_bib0020","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.medmal.2010.10.001","volume":"41","author":"Chidiac","year":"2011","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.ijantimicag.2017.03.027_bib0025","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200405-644ST","article-title":"Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia","volume":"171","author":"American Thoracic Society, Infectious Diseases Society of America","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2017.03.027_bib0030","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1093\/cid\/ciw118","article-title":"Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America","volume":"62","author":"Barlam","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.03.027_bib0035","doi-asserted-by":"crossref","first-page":"ofw020","DOI":"10.1093\/ofid\/ofw020","article-title":"Insight into resistance phenotypes of emergent non 13-valent pneumococcal conjugate vaccine type pneumococci isolated from invasive disease after 13-valent pneumococcal conjugate vaccine implementation in France","volume":"3","author":"Janoir","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.03.027_bib0040","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2147\/IDR.S65928","article-title":"Safety and feasibility of antibiotic de-escalation in bacteremic pneumonia","volume":"7","author":"Khasawneh","year":"2014","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.ijantimicag.2017.03.027_bib0045","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1093\/jac\/dku109","article-title":"Effect of antibiotic streamlining on patient outcome in pneumococcal bacteraemia","volume":"69","author":"Cremers","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2017.03.027_bib0050","first-page":"936","article-title":"De-escalation therapy among bacteraemic patients with community-acquired pneumonia","volume":"21","author":"Carugati","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2017.03.027_bib0055","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/QCO.0000000000000250","article-title":"Macrolide therapy of pneumonia: is it necessary, and how does it help?","volume":"29","author":"Restrepo","year":"2016","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.03.027_bib0060","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00134-013-3077-7","article-title":"De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock","volume":"40","author":"Garnacho-Montero","year":"2014","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ijantimicag.2017.03.027_bib0065","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1007\/s00134-014-3411-8","article-title":"De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: a multicenter non-blinded randomized noninferiority trial","volume":"40","author":"Leone","year":"2014","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ijantimicag.2017.03.027_bib0070","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cmi.2016.05.023","article-title":"Antibiotic de-escalation for bloodstream infections and pneumonia: systematic review and meta-analysis","volume":"22","author":"Paul","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2017.03.027_bib0075","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults","volume":"44","author":"Mandell","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.03.027_bib0080","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1056\/NEJM199701233360402","article-title":"A prediction rule to identify low-risk patients with community-acquired pneumonia","volume":"336","author":"Fine","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2017.03.027_bib0085","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1136\/thoraxjnl-2013-203828","article-title":"Microbial aetiology of healthcare associated pneumonia in Spain: a prospective, multicentre, case-control study","volume":"68","author":"Polverino","year":"2013","journal-title":"Thorax"},{"author":"European Committee on Antimicrobial Susceptibility Testing","key":"10.1016\/j.ijantimicag.2017.03.027_bib0090"},{"key":"10.1016\/j.ijantimicag.2017.03.027_bib0095","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1128\/AAC.49.7.2903-2913.2005","article-title":"Antimicrobial susceptibility of Streptococcus pneumoniae in eight European countries from 2001 to 2003","volume":"49","author":"Reinert","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.03.027_bib0100","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1056\/NEJM199508243330802","article-title":"Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain","volume":"333","author":"Pallares","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2017.03.027_bib0105","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1086\/420821","article-title":"Clinical outcomes of pneumococcal pneumonia caused by antibiotic-resistant strains in asian countries: a study by the Asian Network for Surveillance of Resistant Pathogens","volume":"38","author":"Song","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.03.027_bib0110","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/jac\/dkw441","article-title":"Impact of antibiotic de-escalation on clinical outcomes in community-acquired pneumococcal pneumonia","volume":"72","author":"Viasus","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2017.03.027_bib0115","first-page":"649","article-title":"Elaboration of a consensual definition of de-escalation allowing a ranking of \u03b2-lactams","volume":"21","author":"Weiss","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2017.03.027_bib0120","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1378\/chest.13-1531","article-title":"Decrease in mortality in severe community-acquired pneumococcal pneumonia: impact of improving antibiotic strategies (2000\u20132013)","volume":"146","author":"Gattarello","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.ijantimicag.2017.03.027_bib0125","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1056\/NEJMoa1406330","article-title":"Antibiotic treatment strategies for community-acquired pneumonia in adults","volume":"372","author":"Postma","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2017.03.027_bib0130","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/cc3976","article-title":"Choosing the right combination therapy in severe community-acquired pneumonia","volume":"10","author":"Waterer","year":"2006","journal-title":"Crit Care"},{"key":"10.1016\/j.ijantimicag.2017.03.027_bib0135","doi-asserted-by":"crossref","first-page":"R79","DOI":"10.1186\/cc10072","article-title":"Impact of de-escalation therapy on clinical outcomes for intensive care unit-acquired pneumonia","volume":"15","author":"Joung","year":"2011","journal-title":"Crit Care"},{"key":"10.1016\/j.ijantimicag.2017.03.027_bib0140","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1097\/01.CCM.0000145997.10438.28","article-title":"De-escalation therapy in ventilator-associated pneumonia","volume":"32","author":"Rello","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2017.03.027_bib0145","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1097\/TA.0b013e31819dca4e","article-title":"Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?","volume":"66","author":"Eachempati","year":"2009","journal-title":"J Trauma"},{"key":"10.1016\/j.ijantimicag.2017.03.027_bib0150","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.diagmicrobio.2015.03.004","article-title":"Impact of antimicrobial strategies on clinical outcomes of adults with septic shock and community-onset Enterobacteriaceae bacteremia: de-escalation is beneficial","volume":"82","author":"Lee","year":"2015","journal-title":"Diagn Microbiol Infect Dis"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485791730256X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485791730256X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T08:50:05Z","timestamp":1535619005000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092485791730256X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S092485791730256X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.03.027","relation":{},"ISSN":["0924-8579"],"issn-type":[{"type":"print","value":"0924-8579"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of and obstacles to antibiotic streamlining to amoxicillin monotherapy in bacteremic pneumococcal pneumonia","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.03.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}